Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration on Thursday granted de novo premarket approval for CD Diagnostics' Synovasure Lateral Flow Test Kit used in the detection of periprosthetic joint infection, which occurs around a joint replacement.

The infections manifest in the synovial fluid of patients being evaluated for revision surgery to replace or compensate for a failed implant. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.